TriSalus Life Sciences, Inc.
TLSI
DELAYED 1 MONTH

12 insider filings · Latest: May 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 15, 2026May 19 8:08 PMRichard MarshakChief Commercial Officer
Sale
543$2.67$1.4K125,101(D)

View →

May 15, 2026May 18 8:42 PMWahlstrom MatsDirector
Purchase
60,000$2.53$151.8K147,555(D)

View →

May 15, 2026May 18 8:42 PMStansky Michael PDirector
Purchase
610,000$2.50$1.5M399,698(I)

View →

May 15, 2026May 18 8:42 PMMary T SzelaDirector, CEO and President
Purchase
39,682$2.59$102.8K1,065,215(D)

View →

May 15, 2026May 18 8:42 PMDavid PatienceChief Financial Officer
Purchase
7,100$2.43$17.3K275,757(D)

View →

May 15, 2026May 18 8:42 PMGary B. GordonDirector
Purchase
10,000$2.46$24.6K72,510(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 14, 2026May 15 8:39 PMHICKS KERRY RDirector
Grant/Award
56,403$2.52145,625(D)

View →

May 14, 2026May 15 8:39 PMWahlstrom MatsDirector
Grant/Award
75,204$2.52276,149(D)

View →

May 14, 2026May 15 8:39 PMGary B. GordonDirector
Grant/Award
56,403$2.52112,653(D)

View →

May 14, 2026May 15 8:39 PMMATLIN DAVID JDirector
Grant/Award
56,403$2.52121,403(D)

View →

May 14, 2026May 15 8:39 PMWilliam ValleDirector
Grant/Award
56,403$2.52112,653(D)

View →

May 14, 2026May 15 8:39 PMStansky Michael PDirector
Grant/Award
47,003$2.52139,540(D)

View →